Thursday, July 23

Browsing: neoantigen

Research

A spatial view of tumor neoantigen recognition

By NewsCancerJuly 23, 20260

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.This is a summary…

Research

Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial

By NewsCancerMay 13, 20260

GT-20 trial overviewThis phase 1 clinical trial aimed to assess the safety, feasibility and immunogenicity of a personalized neoantigen DNA…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

What's Hot

Case Study: Individualizing Frontline Therapy in an Older Patient With Comorbidities and Limited Support

A spatial view of tumor neoantigen recognition

Sequencing Beyond Frontline: Resistance, Later-Line Options, and Emerging Directions in EGFR-Mutant NSCLC

Browsing: neoantigen

A spatial view of tumor neoantigen recognition

Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial

Case Study: Individualizing Frontline Therapy in an Older Patient With Comorbidities and Limited Support

A spatial view of tumor neoantigen recognition

Sequencing Beyond Frontline: Resistance, Later-Line Options, and Emerging Directions in EGFR-Mutant NSCLC

Carotuximab/Radium-223 Will Be Evaluated in Bone-Involved Metastatic CRPC

Case Study: Individualizing Frontline Therapy in an Older Patient With Comorbidities and Limited Support

A spatial view of tumor neoantigen recognition

Sequencing Beyond Frontline: Resistance, Later-Line Options, and Emerging Directions in EGFR-Mutant NSCLC

Carotuximab/Radium-223 Will Be Evaluated in Bone-Involved Metastatic CRPC

Latest Post

Case Study: Individualizing Frontline Therapy in an Older Patient With Comorbidities and Limited Support

A spatial view of tumor neoantigen recognition

Sequencing Beyond Frontline: Resistance, Later-Line Options, and Emerging Directions in EGFR-Mutant NSCLC

Subscribe to Updates

What's Hot

Browsing: neoantigen